Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin versus placebo in treatment-resistant papulopustular rosacea
2006-004164-31Phase 3Active
- Sponsor
- Biorga
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of isotretinoin in papulopustular rosacea (2 arms), sponsored by Biorga. Primary endpoint: Primary efficacy endpoint. Started Sep 2006; status: active.
02
Drugs
isotretinoin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on 2006-004164-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004164-31.